Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
PR

PRGO

Market Closed

Perrigo Company plc

NYSEHealthcareDrug Manufacturers - Specialty & Generic
IE
8.10K employees
CEO: Albert A. Manzone
Founded: 1991
$13.04
+$0.00(+NaN%)
Market Cap
1.80B
Beta
0.54
52W Range
N/A
Dividend Yield
8.90%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Perrigo’s current price of $12.64 is significantly below its high-confidence fair value estimate ($87.83), indicating substantial upside potential and low downside risk. Strong DCF valuation contrasts with weak profitability and efficiency scores, reflecting financial health challenges amid growth prospects. Monte Carlo analysis shows extreme volatility but no downside scenarios below the current price, implying asymmetric risk/reward.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PRGO

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PRGO in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →